On 03 September 2025, Hoffmann-La Roche conducted a study is to assess the long-term safety and to explore the efficacy of ...

Monte Rosa Therapeutics stock surged after expanding its Novartis partnership. Click here to learn about their innovative ...

Alzheimer’s disease has proved to be a tricky target, and researchers and drug developers have been pursuing effective treatments for decades. The brains of people who die with Alzheimer’s show a ...

While our understanding of Alzheimer’s disease is far from complete, the latest therapies, and others in more than 100 ...

PDUFA goal date extended by three months from September 7, 2025, to December 7, 2025 CAMBRIDGE, Mass., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage ...

Agios Pharmaceuticals, Inc. awaits FDA review for mitapivat in thalassemia. Approval could boost shares and unlock ...

As radiopharma is gaining momentum, read our interview with Dr. Delpassand, the CEO of RadioMedix's, an established company ...

Scientists have identified tubulin structures in primitive Asgard archea that may have been the precursor of our own cellular ...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced ...

Explore the booming AI funding landscape—over $11.4B invested in enterprise, healthcare, consumer and developer AI tools in ...

Higher activity of PGC-1α enables brown fat cells in females to achieve thermogenic activity and energy expenditure compared ...

Higher activity of PGC-1α enables brown fat cells in females to thermogenic activity and energy expenditure compared to males ...